Research theme for competitive and other funds (2)：
2021 - 2022 Development of a method for detecting F. nucleatum, which is a high risk for colorectal cancer, from saliva
2019 - 2021 Studies on the pathogenicity of Fusobacterium nucleatum isolated from colorectal cancer
Papers (11)：
Mion Ikegami, Hikari Narabayashi, Kazuaki Nakata, Miyu Yamashita, Yutaka Sugi, Yushiro Fuji, Hiroshi Matsufuji, Gaku Harata, Kazutoyo Yoda, Kenji Miyazawa, et al. Intervention in gut microbiota increases intestinal γ-aminobutyric acid and alleviates anxiety behavior: a possible mechanism via the action on intestinal epithelial cells. Frontiers in Cellular and Infection Microbiology. 2024. 14
Kyoko Takahashi, Yutaka Sugi, Kou Nakano, Tetsuro Kobayakawa, Yusuke Nakanishi, Masato Tsuda, Akira Hosono, Shuichi Kaminogawa. Regulation of Gene Expression through Gut Microbiota-Dependent DNA Methylation in Colonic Epithelial Cells. ImmunoHorizons. 2020. 4. 4. 178-190
Yasuhiko Komiya, Yumi Shimomura, Takuma Higurashi, Yutaka Sugi, Jun Arimoto, Shotaro Umezawa, Shiori Uchiyama, Mitsuharu Matsumoto, Atsushi Nakajima. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut. 2018
Kazuaki Nakata, Yutaka Sugi, Hikari Narabayashi, Tetsuro Kobayakawa, Yusuke Nakanishi, Masato Tsuda, Akira Hosono, Shuichi Kaminogawa, Shigemasa Hanazawa, Kyoko Takahashi. Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4. JOURNAL OF BIOLOGICAL CHEMISTRY. 2017. 292. 37. 15426-15433
ヒトの脳の膿瘍から単離されたStreptococcus intermedius TYG1620株の病原性の特徴(Characterization of the pathogenicity of Streptococcus intermedius TYG1620 isolated from a human brain abscess)
(日本細菌学雑誌 2017)
